Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1036

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 3
Chunk 1036
---
From
time to time, we are involved in various legal proceedings arising from the normal course of business activities. We are not presently
a party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have
a material adverse effect on our business, operating results, cash flows or financial condition. Defending such proceedings is costly
and can impose a significant burden on management and employees. The results of any current or future litigation cannot be predicted
with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion
of management resources, and other factors.

ITEM
4. MINE SAFETY DISCLOSURES

Not
applicable.

81

PART
II

ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market
Information

Our
common stock is listed on The Nasdaq Capital Market and its stock symbol is “JUNS.” The closing price of our common stock
on The Nasdaq Capital Market on March 28, 2025 was $0.70.

Holders

As
of March 28, 2025, there were 33,103,860 shares of common stock issued and outstanding, and we had approximately 31 holders
of record of our common stock.  The number of record holders does not include beneficial owners of common stock whose shares are
held in the names of banks, brokers, nominees or other fiduciaries.

Dividends

We
have not declared or paid any cash dividends on our common stock since our inception, and do not currently anticipate paying cash dividends
in the foreseeable future. We intend to retain future earnings, if any, for reinvestment in the development and expansion of our business.

Securities
Authorized for Issuance Under Equity Compensation Plans

The
Company’s stockholders approved the 2016 Equity Incentive Plan (“2016 Plan”) on January 4, 2016. Under the 2016 Plan,
as modified, 8,437,500 shares of common stock are authorized for issuance to employees, officers, directors, consultants. The 2016 Plan
authorizes the grant of nonqualified stock options and incentive stock options, restricted stock awards, restricted stock units, stock
appreciation rights, under the 2016 Plan. The Company does not intend to make any grants